These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2023881)

  • 1. Prediction of acute graft rejection in renal transplantation: the utility of cyclosporine blood concentrations.
    Grevel J; Napoli KL; Welsh MS; Atkinson NE; Kahan BD
    Pharm Res; 1991 Feb; 8(2):278-81. PubMed ID: 2023881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipients.
    Schroeder TJ; Brunson ME; Pesce AJ; Hindenlang LL; Mauser PA; Ruckrigl DI; Weibel ML; Wadih G; First MR
    Transplantation; 1989 Feb; 47(2):262-6. PubMed ID: 2645710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.
    Lindholm A; Dahlqvist R; Groth GG; Sjöqvist F
    Br J Clin Pharmacol; 1990 Sep; 30(3):443-52. PubMed ID: 2223423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of renal allograft dysfunction upon cyclosporine trough levels in host blood.
    Arnold AN; Waltzer WC; Anaise D; Weinstein SW; Rapaport FT
    Transplantation; 1985 Dec; 40(6):605-10. PubMed ID: 3907030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple therapy in cadaveric renal transplantation: role of induction cyclosporine and targeted levels to avoid rejection.
    Khauli RB; Wilson JM; Baker SP; Valliere SA; Lovewell TD; Stoff JS
    J Urol; 1995 Jun; 153(6):1805-9; discussion 1810. PubMed ID: 7752322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a therapeutic range for monitoring plasma cyclosporin in renal allograft recipients?
    Ubhi CS; Woodhouse L; Guillou PJ; Giles GR
    Nephrol Dial Transplant; 1988; 3(6):814-9. PubMed ID: 3147426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine plasma levels in renal transplant patients. Association with renal toxicity and allograft rejection.
    Klintmalm G; Säwe J; Ringdén O; von Bahr C; Magnusson A
    Transplantation; 1985 Feb; 39(2):132-7. PubMed ID: 3881851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA
    Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of whole blood cyclosporine measurements in renal transplantation using triple therapy.
    Nankivell BJ; Hibbins M; Chapman JR
    Transplantation; 1994 Nov; 58(9):989-96. PubMed ID: 7974738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation.
    Min DI; Perry PJ; Chen HY; Hunsicker LG
    Pharmacotherapy; 1998; 18(2):282-7. PubMed ID: 9545147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective long-term immunosuppression maintained by low cyclosporine levels in primary cadaveric renal transplant recipients.
    Kupin WL; Venkat KK; Norris C; Florence-Green D; Dienst S; Oh HK; Feldkamp C; Levin NW
    Transplantation; 1987 Feb; 43(2):214-8. PubMed ID: 3544378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period?
    Mahalati K; Lawen J; Kiberd B; Belitsky P
    J Urol; 2000 Jan; 163(1):37-41. PubMed ID: 10604309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the variability of cyclosporin A trough levels on long-term renal allograft function.
    Waiser J; Slowinski T; Brinker-Paschke A; Budde K; Schreiber M; Böhler T; Hauser I; Neumayer HH
    Nephrol Dial Transplant; 2002 Jul; 17(7):1310-7. PubMed ID: 12105257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood levels of cyclosporine, acute rejections and the prognosis of the allografts in pediatric renal allograft recipients].
    Sakuma T; Ogawa O; Kawamura T; Hasegawa A; Kamidono S
    Nihon Hinyokika Gakkai Zasshi; 1995 Sep; 86(9):1450-9. PubMed ID: 7474634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state concentration of cyclosporin G (OG37-325) and its metabolites in renal transplant recipients.
    Langman LJ; Leichtman AB; Weitzel WF; Yatscoff RW
    Clin Chem; 1994 Apr; 40(4):613-6. PubMed ID: 8149619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trial.
    Perico N; Ruggenenti P; Gotti E; Gaspari F; Cattaneo D; Valente U; Salvadori M; Segoloni G; Donati D; Sandrini S; Ganeva M; Dimitrov BD; Remuzzi G;
    Kidney Int; 2004 Mar; 65(3):1084-90. PubMed ID: 14871429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in blood.
    Moyer TP; Post GR; Sterioff S; Anderson CF
    Mayo Clin Proc; 1988 Mar; 63(3):241-7. PubMed ID: 3278174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.
    Lindholm A; Kahan BD
    Clin Pharmacol Ther; 1993 Aug; 54(2):205-18. PubMed ID: 8354028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased circulating concentrations of interleukin 2 receptor during rejection episodes in heart- or kidney-transplant recipients.
    Zucchelli GC; Clerico A; De Maria R; Carmellini M; Di Stefano R; Masini S; Pilo A; Donato L
    Clin Chem; 1990 Dec; 36(12):2106-9. PubMed ID: 2253354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically Significant Drug Interaction Between Clotrimazole and Tacrolimus in Pancreas Transplant Recipients and Associated Risk of Allograft Rejection.
    Viesselmann CW; Descourouez JL; Jorgenson MR; Radke NA; Odorico JS
    Pharmacotherapy; 2016 Mar; 36(3):335-41. PubMed ID: 26877191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.